10a,12a-dimethyl-2,3,3a,3b,4,5,8,9,10,10b,11,12-dodecahydroindeno[4,5-i][3]benzazepine-1,7-dione
Modify Date: 2024-02-12 08:39:09
![10a,12a-dimethyl-2,3,3a,3b,4,5,8,9,10,10b,11,12-dodecahydroindeno[4,5-i][3]benzazepine-1,7-dione Structure](https://www.chemsrc.com/caspic/104/20986-87-2.png)
10a,12a-dimethyl-2,3,3a,3b,4,5,8,9,10,10b,11,12-dodecahydroindeno[4,5-i][3]benzazepine-1,7-dione structure
|
Common Name | 10a,12a-dimethyl-2,3,3a,3b,4,5,8,9,10,10b,11,12-dodecahydroindeno[4,5-i][3]benzazepine-1,7-dione | ||
|---|---|---|---|---|
| CAS Number | 20986-87-2 | Molecular Weight | 301.42300 | |
| Density | 1.14g/cm3 | Boiling Point | 500.2ºC at 760 mmHg | |
| Molecular Formula | C19H27NO2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 177.1ºC | |
| Name | 10a,12a-dimethyl-2,3,3a,3b,4,5,8,9,10,10b,11,12-dodecahydroindeno[4,5-i][3]benzazepine-1,7-dione |
|---|---|
| Synonym | More Synonyms |
| Density | 1.14g/cm3 |
|---|---|
| Boiling Point | 500.2ºC at 760 mmHg |
| Molecular Formula | C19H27NO2 |
| Molecular Weight | 301.42300 |
| Flash Point | 177.1ºC |
| Exact Mass | 301.20400 |
| PSA | 46.17000 |
| LogP | 3.57320 |
| Vapour Pressure | 3.87E-10mmHg at 25°C |
| Index of Refraction | 1.561 |
|
~%
10a,12a-dimethy... CAS#:20986-87-2 |
| Literature: Camoutsis; Catsoulacos Journal of Heterocyclic Chemistry, 1983 , vol. 20, # 4 p. 1093 - 1094 |
|
~%
10a,12a-dimethy... CAS#:20986-87-2 |
| Literature: Camoutsis; Catsoulacos Journal of Heterocyclic Chemistry, 1983 , vol. 20, # 4 p. 1093 - 1094 |
|
~%
10a,12a-dimethy... CAS#:20986-87-2 |
| Literature: Camoutsis; Catsoulacos Journal of Heterocyclic Chemistry, 1983 , vol. 20, # 4 p. 1093 - 1094 |
|
~%
10a,12a-dimethy... CAS#:20986-87-2 |
| Literature: BIOMARIN PHARMACEUTICAL INC.; CHU, Daniel; WANG, Bing; YE, Tao Patent: WO2012/83112 A2, 2012 ; WO 2012/083112 A2 |
|
~%
10a,12a-dimethy... CAS#:20986-87-2 |
| Literature: BIOMARIN PHARMACEUTICAL INC.; CHU, Daniel; WANG, Bing; YE, Tao Patent: WO2012/83112 A2, 2012 ; WO 2012/083112 A2 |
|
~%
10a,12a-dimethy... CAS#:20986-87-2 |
| Literature: BIOMARIN PHARMACEUTICAL INC.; CHU, Daniel; WANG, Bing; YE, Tao Patent: WO2012/83112 A2, 2012 ; WO 2012/083112 A2 |
![1-hydroxy-10a,12a-dimethyl-2,3,3a,3b,4,5,8,9,10,10b,11,12-dodecahydro-1H-indeno[4,5-i][3]benzazepin-7-one structure](https://www.chemsrc.com/caspic/029/21058-56-0.png)
![(10a,12a-dimethyl-7-oxo-2,3,3a,3b,4,5,8,9,10,10b,11,12-dodecahydro-1H-indeno[4,5-i][3]benzazepin-1-yl) acetate structure](https://www.chemsrc.com/caspic/077/21058-55-9.png)
![[(3Z)-3-hydroxyimino-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate structure](https://www.chemsrc.com/caspic/426/59285-18-6.png)
| 5a,7a-dimethyl-3,4,5,5a,5b,6,7,7a,9,10,10a,10b,11,12-tetradecahydrocyclopenta[5,6]naphtho[1,2-d]azepine-2,8-dione |